Seattle Children’s Launches New Eosinophilic Gastrointestinal Disorders Program

The expert team at the new Eosinophilic Gastrointestinal Disorders (EGID) Program at Seattle Children’s knows the unique challenges in the diagnosis and management of patients with these conditions. With symptoms that span gastrointestinal, immunologic and nutritional, patients benefit from collaborative care involving multiple specialties. The new program is designed with this in mind, offering a range of innovative services and expert-led clinics to streamline evaluation, diagnosis and treatments.

The EGID Program has a multidisciplinary team that focuses on improving access, reducing invasive testing where possible and providing a seamless patient experience. For example, patients with eosinophilic esophagitis have access to minimally invasive, sedation-free methods of evaluating disease activity, including esophageal string testing and transnasal endoscopy. The goal is to help reduce the burden of repeated sedated procedures for patients requiring frequent monitoring.

Beyond clinical care, patients have access to participate in ongoing research. The EGID Program includes dedicated research coordinators and a research scientist exploring innovative management strategies for these conditions, ensuring that families have access to emerging therapies and cutting-edge insights.

Clinics are available monthly at Seattle Children’s Hospital campus and provide streamlined care for screening and follow-up for patients with eosinophilic gastrointestinal disorders.

Why choose Seattle Children’s EGID Program?

The Seattle Children’s EGID Program elevates the quality of care through specialized expertise, comprehensive coordinated care and advanced diagnostics and therapeutics.

We are also committed to our partnership with community providers through a collaborative, shared-care approach. Patients can receive specialty assessments and advanced diagnostics while continuing routine follow-up locally. The new program prioritizes open communication to keep community providers informed and engaged.

Seattle Children’s is committed to ongoing collaboration with community providers and expanding access to care for children with eosinophilic gastrointestinal disorders across the region. Future plans include increasing clinic frequency, expanding mental health support and introducing additional clinical trials.

For more information: Visit the Gastroenterology refer a patient page for more information on how to refer a patient. If your team would like to learn more about the EGID Program by scheduling a meet-and-greet or education with program faculty, please reach out to your dedicated physician liaison.